Clinical Trials on Controlled Asthma in Italy
Total 167 results
-
Menarini International Operations Luxembourg SACompletedAsthma | Seasonal Allergic RhinoconjunctivitisPoland, Romania, Germany, Italy, Czechia, Latvia, Croatia, Slovakia
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, Belgium, Japan, France, Netherlands, Canada, Italy, Slovakia, United States, Hungary
-
Novartis PharmaceuticalsRecruitingAsthmaItaly, Spain, Austria, Portugal, Argentina, South Africa, Greece, Hungary, Colombia, Mexico, Guatemala, Romania, Czechia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Canada, France, Netherlands, Spain, Ukraine, Bulgaria, Estonia, Belgium, Peru, Russian Federation, Germany, Greece, Czechia, Italy, United Kingdom, Norway, Slovakia
-
GlaxoSmithKlineCompletedAsthmaUnited States, Canada, Germany, Spain, Netherlands, Italy, United Kingdom
-
AstraZenecaCompletedAsthmaGermany, Hungary, India, Italy, Canada, France
-
AstraZenecaRecruitingAsthmaCanada, Israel, Belgium, Switzerland, Germany, Italy, Sweden, Austria, Denmark
-
Boehringer IngelheimCompletedAsthmaUnited States, Austria, Germany, Italy, Korea, Republic of, New Zealand, Sweden, Turkey, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Mexico, United States, Hungary, Italy, Argentina, Australia, Brazil, Canada, Chile, Colombia, Lithuania, Poland, Romania, Russian Federation, South Africa, Turkey, Ukraine
-
GlaxoSmithKlineCompletedAsthmaGermany, Romania, Bulgaria, Chile, Russian Federation, South Africa, Estonia, Italy, Mexico, Greece, Hungary, Croatia, Brazil
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaBelgium, Israel, United States, Mexico, Argentina, Brazil, Canada, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, Ukraine
-
GlaxoSmithKlineCompletedAsthmaRussian Federation, Belgium, Poland, Spain, Denmark, Italy, Sweden, Netherlands, France, Lithuania, Latvia, Norway
-
Boehringer IngelheimPfizerCompletedAsthmaArgentina, Austria, Croatia, Estonia, Guatemala, Hungary, India, Italy, Korea, Republic of, Latvia, Poland, Slovakia
-
GlaxoSmithKlineIqvia Pty LtdRecruitingAsthmaUnited States, Australia, Canada, France, Germany, Italy, Japan, Poland, Spain, China, Czechia, Hungary, Taiwan, United Kingdom
-
GlaxoSmithKlineIqvia Pty LtdCompletedAsthmaUnited States, France, Germany, Poland, Spain, Italy, United Kingdom, China, Canada, Czechia, Russian Federation, Ireland
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Chile, Germany, Hungary, Italy, Korea, Republic of, Latvia, Mexico, Russian Federation, Slovakia, Spain, Ukraine
-
Hoffmann-La RocheCompletedAsthmaUnited States, United Kingdom, Belgium, Canada, France, Germany, Bulgaria, Denmark, Hungary, Italy, Latvia, Netherlands, Portugal, Russian Federation, Spain
-
Novartis PharmaceuticalsTerminatedAsthmaGermany, United States, Korea, Republic of, Poland, United Kingdom, Israel, Russian Federation, Italy, Turkey, Argentina, France, Hungary, Mexico, Canada, Czechia, Finland, Portugal, Romania, Slovakia, South Africa
-
Regeneron PharmaceuticalsSanofiActive, not recruitingAsthmaUnited States, United Kingdom, Canada, France, Puerto Rico, Japan, Spain, Denmark, Italy, Sweden
-
GlaxoSmithKlineIqvia Pty LtdActive, not recruitingAsthmaUnited States, Japan, Poland, Spain, Italy, Australia, Taiwan, France, Hungary, Canada, Czechia
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaMexico, Spain, Argentina, Japan, Poland, United States, Turkey, Australia, Brazil, Canada, Chile, Colombia, Hungary, Italy, Lithuania, Russian Federation, South Africa, Ukraine
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, Mexico, Italy, United Kingdom
-
GlaxoSmithKlineRecruitingAsthmaUnited States, Italy, Panama, Spain, Canada, Poland, Australia, Argentina, France, Greece, Philippines, Thailand, United Kingdom
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Spain, United States, Turkey, Canada, Hungary, Slovakia, Italy, Argentina, Czech Republic, France, Peru
-
AstraZenecaRecruitingAsthmaUnited States, Canada, Italy, Japan, Vietnam, Spain, Germany, Malaysia
-
AmgenAstraZeneca; Kyowa Kirin Co., Ltd.TerminatedAsthmaUnited States, Canada, France, Germany, Italy, Taiwan, Hong Kong, Australia, Greece, Russian Federation, Poland, Ireland, Puerto Rico, Korea, Republic of, New Zealand
-
Novartis PharmaceuticalsCompletedAsthmaGermany, United States, India, Korea, Republic of, Italy, Russian Federation, Sweden, Israel, Spain, Peru, Brazil, Bulgaria, Hungary, Vietnam, Canada, Colombia, Puerto Rico, Tunisia
-
Boehringer IngelheimCompletedAsthmaAustria, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Russian Federation, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
AstraZenecaCompletedAsthmaUnited Kingdom, Switzerland, Belgium, France, Italy, Spain, Netherlands
-
SanofiActive, not recruitingDose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)AsthmaUnited States, Argentina, Brazil, Canada, Chile, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, South Africa, Turkey, United Kingdom
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthmaAustria, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Australia, Canada, Denmark, Germany, Italy, Japan, Netherlands, New Zealand, Russian Federation, Serbia, South Africa, Turkey, Ukraine, United Kingdom
-
Novartis PharmaceuticalsCompletedAsthmaUnited States, Colombia, India, Romania, South Africa, Italy, Hungary, France, Bulgaria, Turkey, Greece, Guatemala, Japan, Argentina, Austria, Mexico, Netherlands, Peru, Poland, Russian Federation, United Kingdom, Canada
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Australia, Canada, France, Germany, Japan, Netherlands, Poland, Russian Federation, Spain, Ukraine, Belgium, Chile, Korea, Republic of, United Kingdom, Czechia, Mexico, Italy
-
SanofiRegeneron PharmaceuticalsActive, not recruitingAsthmaPortugal, Ukraine, Spain, Taiwan, Sweden, United States, Bulgaria, Denmark, France, Italy, Romania, Saudi Arabia, United Kingdom
-
AstraZenecaRecruitingAsthmaUnited States, Argentina, Italy, Mexico, Germany, Hungary, Netherlands, Poland, Spain, Korea, Republic of, Bulgaria, Ukraine, Serbia, Turkey, Slovakia, United Kingdom, Chile, Australia, Croatia, Japan, Romania, South Africa, France, S...
-
Novartis PharmaceuticalsCompletedAsthmaUnited States, India, Spain, Italy, Israel, Netherlands, Russian Federation, Lebanon, South Africa, Czechia, Greece, Serbia, Argentina, Mexico, Slovakia, Canada, Taiwan, Malaysia, Japan
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive | AsthmaNetherlands, Germany, Belgium, France, Canada, Italy, South Africa, Denmark
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Australia, Canada, Denmark, Germany, Italy, Japan, Netherlands, Russian Federation, Serbia, South Africa, Turkey, Ukraine, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Canada, Denmark, Belgium, Japan, Korea, Republic of, Mexico, United States, Israel, Brazil, Australia, France, Germany, United Kingdom, Argentina, Chile, Colombia, Hungary, Italy, Netherlands, Poland, Romania, Russian Federation and more
-
UCB PharmaTerminatedAsthmaItaly, Poland, United Kingdom, Germany, Spain, Belgium, South Africa, Czech Republic, Australia, France
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, United States, Chile, Australia, France, Mexico, Argentina, Italy, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, Korea, Republic of, New Zealand
-
Hoffmann-La RocheCompletedAsthmaUnited States, United Kingdom, Hungary, Korea, Republic of, Spain, Brazil, Taiwan, Israel, Peru, France, Italy, South Africa, Germany, Poland, Colombia, Argentina, Mexico, Czechia, Ukraine, Slovakia, Canada, Japan, Portugal
-
GlaxoSmithKlineCompletedAsthmaAustralia, United States, Argentina, Canada, Germany, Japan, Korea, Republic of, Romania, Russian Federation, Spain, South Africa, Netherlands, Poland, Italy, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedAsthmaSpain, Canada, United States, Korea, Republic of, Mexico, Brazil, Germany, Taiwan, Argentina, Australia, Colombia, France, Hungary, Japan, Poland, Russian Federation, South Africa, Turkey, Ukraine, United Kingdom, Italy, Chile
-
GlaxoSmithKlineIqvia Pty LtdRecruitingAsthmaUnited States, Australia, Austria, Canada, Finland, France, Germany, Ireland, Italy, Japan, Netherlands, Norway, Puerto Rico, Slovenia, Spain, Sweden, Switzerland, Taiwan, United Kingdom, Israel, Portugal
-
Chiesi Farmaceutici S.p.A.CompletedAsthmaArgentina, Belarus, Bulgaria, Czechia, Germany, Hungary, Italy, Lithuania, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Turkey, Ukraine, United Kingdom
-
AstraZenecaRecruitingAsthmaUnited States, Canada, Denmark, Hungary, New Zealand, Poland, Spain, Korea, Republic of, Philippines, Italy, Argentina, Bulgaria, India, Japan, Vietnam, Taiwan, Thailand, Peru, Chile, Puerto Rico, Belgium, Australia, Netherlands, Romania
-
Novartis PharmaceuticalsCompletedAsthmaGermany, Belgium, India, Romania, South Africa, Croatia, Estonia, Russian Federation, Netherlands, Israel, Thailand, Lebanon, Canada, Philippines, Poland, Slovakia, United Kingdom, China, Latvia, Italy, Argentina, Greece, Mexico, Austria and more
-
AstraZenecaCompletedAsthmaUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Spain, Sweden, United Kingdom